| ID Source | ID |
|---|---|
| PubMed CID | 19507 |
| CHEMBL ID | 377716 |
| SCHEMBL ID | 161762 |
| SCHEMBL ID | 14714953 |
| MeSH ID | M0240403 |
| Synonym |
|---|
| AC-713 |
| BB 0256548 |
| 1-azabicyclo[2.2.2]octan-8-one |
| nsc-168448 |
| 3-quinuclidinone |
| 3-quinuclidone |
| quinuclidone |
| 1-azabicyclo[2.2.2]octan-3-one |
| 3-oxoquinuclidine |
| mkc-2 |
| nsc168448 |
| 3731-38-2 |
| quinuclidin-3-one |
| inchi=1/c7h11no/c9-7-5-8-3-1-6(7)2-4-8/h6h,1-5h |
| STL069553 |
| CHEMBL377716 |
| AKOS000119728 |
| A823593 |
| AKOS015949293 |
| unii-p4vf4g5pta |
| nsc 168448 |
| p4vf4g5pta , |
| ec 223-087-9 |
| einecs 223-087-9 |
| 1-azabicyclo(2.2.2)octan-3-one |
| FT-0616381 |
| S12072 |
| CS-B0309 |
| SCHEMBL161762 |
| J-504207 |
| quinuclidine-3-one |
| 1-aza-bicyclo[2.2.2]octan-3-one |
| DTXSID0063151 |
| quinuclidone 3 |
| SCHEMBL14714953 |
| 1-azabicyclo[2.2.2]octan-3-one, base form |
| mfcd06801385 |
| AMY25660 |
| SB36886 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID261193 | Viability of H1299 (p53 null) cells at 4 mM by MTT assay | 2006 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 16, Issue:5 | Structure-activity studies of quinuclidinone analogs as anti-proliferative agents in lung cancer cell lines. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||